april 26, 2004----jesup and lamont retained by commonwealth biotechnologies. They were seeking equity capitol to upgrade and equip their accredited biosafety level 3 laboratory suite.
May 28, 2004-----Commonwealth Biotechnologies, Inc. Closes $2.5M Private Placement. Jesup & Lamont Securities, Corp. acted as exclusive placement agent for the transaction.
This is just a hypothesis....but is this what is down the road for cygx in a few months? CYGX wants to build a new facility and that takes serious funding. Does Jesup and Lamont have deep pockets interested in biotech research and that is why cygx has retained them....or am I drawing to many paralells???
Comments appreciated It would certainly help them avoid some dilution.....
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.